A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with Complicated SAB Receiving Standard-of-Care Antibiotics ✅ Just Accepted https://bit.ly/4z3L73t
Comparison of Silevimig, a Novel Bispecific Anti-Rabies Monoclonal Antibody, with Human Rabies Immunoglobulin for Post-Exposure Prophylaxis: A Phase III, Randomized, Double-Blind, Non-Inferiority Trial ✅ Just Accepted https://bit.ly/4jkAa9d
High mortality in adults with community-acquired pneumonia admitted to hospitals in South Africa before and during the COVID-19 pandemic, stratified by HIV-serostatus and viral load: data from a prospective cohort study (2019-2021) ✅ Just Accepted 🔗 https://bit.ly/4hLKEfF
Update of the Ebola virus disease outbreak in DRC - 7 Sep: On 6 Sep, DRC reported 6 604 (+82) cases & 3 175 (+41) deaths. 851 patients remain in isolation. EU/EEA risk assessment remains VERY LOW. Info: bit.ly/ECDCEbolaDRC #PublicHealth #Ebola #IDsky #EpiSky
New Research, oral presentation, Lancet Late Breaker session, #ESCMIDGlobal2026, 20 April Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study www.thelancet.com/journals/lan...
A new meta-analysis finds alarming increases in colistin resistance among Acinetobacter baumannii and Pseudomonas aeruginosa across Africa, threatening the effectiveness of one of the last-resort antibiotics. #IDsky #Medsky www.contagionlive.com/view/rising-...
On IDSA’s/HIVMA’s Science Speaks: A study in CID examined associations between antibiotic use & outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. https://bit.ly/46mQEq6
Study: Antibiotic resistance threatens 30-year decline in deaths from lower respiratory infections Global data show deaths from lower respiratory infections declined from 1990 to 2021, but the share of deaths from drug-resistant infections is rising. www.cidrap.umn.edu/a...
Through systems immunology analysis, a team has identified potential therapeutic targets for the treatment of #UlcerativeColitis, an inflammatory bowel disease characterized by dysregulated cytokine signaling in the GI tract. #ScienceSignaling https://scim.ag/4cdvxdv